ConductScience.org, home

Gene · 9582

APOBEC3B: apolipoprotein B mRNA editing enzyme catalytic subunit 3B

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. APOBEC3B: apolipoprotein B mRNA editing enzyme catalytic subunit 3B. Genes, record 9582. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/9582

On this page

Gene

Symbol
APOBEC3B
HGNC
Name
apolipoprotein B mRNA editing enzyme catalytic subunit 3B
HGNC
NCBI Gene ID
9582
NCBI Gene
HGNC ID
HGNC:17352
HGNC
Ensembl
ENSG00000179750
NCBI Gene
Aliases
A3B, APOBEC1L, ARCD3, ARP4, DJ742C19.2, FLJ21201, PHRBNL, bK150C2.2
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q9UH17DNA dC->dU-editing enzyme APOBEC-3B38213Ensembl, GeneID, HGNC

Source UniProt

Patents200

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4828972 A12026-10-2837Q9UH17Espacenet
EP 4828972 A12026-10-28582Q9UH17Espacenet
EP 4828972 A12026-10-28631Q9UH17Espacenet
JP 2026525611 A2026-07-3170Q9UH17Espacenet
JP 2026525612 A2026-07-31503Q9UH17Espacenet
EP 4777618 A12026-07-2237Q9UH17Espacenet
EP 4777618 A12026-07-22582Q9UH17Espacenet
EP 4777618 A12026-07-22631Q9UH17Espacenet
JP 2026116287 A2026-07-09274Q9UH17Espacenet
EP 4762095 A12026-06-2437Q9UH17Espacenet

1 to 10 of 200

See all 200 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,186

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleAPOBEC3B papersNewest fiscal year
P01CA234228APOBEC Mutagenesis in Cancer442025
P30CA008748Cancer Center Support Grant262025
T32CA009138Molecular, Genetic and Cellular Targets of Cancer Training Program202025
T32AI083196Minnesota Training Program in Virology172025
P30CA016672Cancer Center Support Grant152025
R37CA252081Molecular Mechanisms of APOBEC-Induced Mutagenesis in Cancer142025
R35GM118047Structural studies of viral replication and invasion132025
P30AI027763UCSF-Bay Area Center for AIDS Research102025
ZIAES103266Genome-wide hypermutation and structural instability102025
P30CA077598Cancer Center Support Grant92025

1 to 10 of 1,186Source NIH's project files

See all 1,186 nih grants

Papers1,875

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
APOBEC3 activity and DNA polymerase-ε deficiency are associated with distinct IDH1 R132 hotspot mutations.Mol Oncol202642717521PubTator, text miningPubMed
Fluorescence polarization-based fragment screen identifies inhibitors of APOBEC3A and APOBEC3B.bioRxiv202642620011PubTator, text miningPubMed
Association of APOBEC mutagenesis with stromal and endothelial niche remodeling and PCDH9-linked signaling alterations in colorectal cancer.Front Immunol202642535079PubTator, text miningPubMed
Distinct repair processes produce APOBEC-induced deletions, tandem substitutions, and complex mutations in yeast and human cells.Proc Natl Acad Sci U S A202642520125PubTator, text miningPubMed
Multiomic profiling links L1 retrotransposition to genomic instability and ecDNA in bladder cancer.Nat Commun202642463649PubTator, text miningPubMed
Collapsing retroviruses for efficient delivery of viro-toxic cargoes.bioRxiv202642427788PubTator, text miningPubMed
The regulatory mechanism and clinical significance of RNA editing in prostate cancer.Curr Urol202642368672PubTator, text miningPubMed
Full-length structure of the anti-viral and pro-tumor DNA deaminase APOBEC3B.bioRxiv202642367898PubTator, text miningPubMed
Shared diagnostic biomarkers in metabolic syndrome and coronary artery disease identified by integrated bioinformatics and machine learning.Endocr Connect202642160392PubTator, text miningPubMed
Identification of Immune-Related Diagnostic Genes and Subtypes of Active Ulcerative Colitis.Iran J Allergy Asthma Immunol202642130146PubTator, text miningPubMed

1 to 10 of 1,875

See all 1,875 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/9582

GET https://conductscience.org/api/genes/v1/9582/patents?page=2